Ancestral diversity is limited in published T cell receptor sequencing studies.
作者信息
Huang Yu-Ning, Peng Kerui, Popejoy Alice B, Hu Jieting, Nowicki Theodore Scott, Gold Stefan M, Quintana-Murci Lluis, Fuentes-Guajardo Macarena, Shugay Mikhail, Greiff Victor, Burkhardt Amanda M, Alachkar Houda, Mangul Serghei
机构信息
Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA.
Department of Biomedical Data Science, Stanford University, Stanford, CA 94305, USA.
出版信息
Immunity. 2021 Oct 12;54(10):2177-2179. doi: 10.1016/j.immuni.2021.09.015.
Abstract
摘要
相似文献
1
Ancestral diversity is limited in published T cell receptor sequencing studies.在已发表的T细胞受体测序研究中，祖先多样性有限。
Immunity. 2021 Oct 12;54(10):2177-2179. doi: 10.1016/j.immuni.2021.09.015.
2
Human and mouse T-cell receptor loci: genomics, evolution, diversity, and serendipity.人类和小鼠的T细胞受体基因座：基因组学、进化、多样性及意外发现。
Ann N Y Acad Sci. 1995 Jun 30;758:390-412. doi: 10.1111/j.1749-6632.1995.tb24844.x.
3
High-throughput sequencing insights into T-cell receptor repertoire diversity in aging.高通量测序揭示衰老过程中T细胞受体库的多样性
Genome Med. 2015 Nov 19;7(1):117. doi: 10.1186/s13073-015-0242-3.
4
T cell receptor gene diversity and selection.
Annu Rev Biochem. 1990;59:475-96. doi: 10.1146/annurev.bi.59.070190.002355.
5
Assessing human B cell repertoire diversity and convergence.评估人类 B 细胞 repertoire 多样性和收敛性。
Immunol Rev. 2018 Jul;284(1):51-66. doi: 10.1111/imr.12670.
6
TCR diversity - a universal cancer immunotherapy biomarker?T 细胞受体多样性——一种通用的癌症免疫治疗生物标志物？
J Immunother Cancer. 2016 Nov 15;4:69. doi: 10.1186/s40425-016-0175-4. eCollection 2016.
7
Estimating diversity, the easy way.轻松估算多样性。
Nat Methods. 2006 Nov;3(11):879-80. doi: 10.1038/nmeth1106-879.
8
Diversity, development, ligands, and probable functions of gamma delta T cells.γδ T细胞的多样性、发育、配体及可能的功能
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:31-44. doi: 10.1101/sqb.1989.054.01.005.
9
[T-lymphocyte receptor genes: genome organization and genetic mechanisms of repertoire diversity].[T淋巴细胞受体基因：基因组组织与受体库多样性的遗传机制]
Rev Rhum Ed Fr. 1994;61(7-8):521-31.
10
IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs.IMGT/连接分析：用于分析免疫球蛋白和T细胞受体复合物V-J及V-D-J连接的首个工具。
Bioinformatics. 2004 Aug 4;20 Suppl 1:i379-85. doi: 10.1093/bioinformatics/bth945.
引用本文的文献
1
The systematic assessment of completeness of public metadata accompanying omics studies in the Gene Expression Omnibus data repository.对基因表达综合数据库（Gene Expression Omnibus data repository）中组学研究附带的公共元数据完整性的系统评估。
Genome Biol. 2025 Sep 9;26(1):274. doi: 10.1186/s13059-025-03725-0.
2
The systematic assessment of completeness of public metadata accompanying omics studies in the Gene Expression Omnibus.对基因表达综合数据库中组学研究相关公共元数据完整性的系统评估。
bioRxiv. 2025 Jul 7:2021.11.22.469640. doi: 10.1101/2021.11.22.469640.
3
Perceptual and technical barriers in sharing and formatting metadata accompanying omics studies.组学研究中伴随元数据的共享与格式化方面的感知和技术障碍。
Cell Genom. 2025 May 14;5(5):100845. doi: 10.1016/j.xgen.2025.100845. Epub 2025 Apr 10.
4
Huanglian decoction prevents and treats radiation-induced intestinal injury in lung cancer by regulating endoplasmic reticulum stress.黄连汤通过调节内质网应激防治肺癌放射性肠损伤。
J Nat Med. 2025 Jan;79(1):143-161. doi: 10.1007/s11418-024-01860-9. Epub 2024 Dec 5.
5
Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations.抗癌治疗疗效的祖先差异及其潜在的基因组和分子改变。
Cancer Discov. 2025 Mar 3;15(3):511-529. doi: 10.1158/2159-8290.CD-24-0827.
6
Low booster uptake in cancer patients despite health benefits.尽管有健康益处，但癌症患者的加强针接种率较低。
iScience. 2024 Jul 26;27(9):110596. doi: 10.1016/j.isci.2024.110596. eCollection 2024 Sep 20.
7
TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance.T 细胞受体（TCR）库景观揭示了内毒素耐受中巨噬细胞介导的克隆缺失。
Inflamm Res. 2023 Mar;72(3):531-540. doi: 10.1007/s00011-022-01685-w. Epub 2023 Jan 12.
本文引用的文献
1
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.辉瑞-生物科技和莫德纳 COVID-19 疫苗在医护人员中的疫苗有效性的临时估计 - 2021 年 1 月至 3 月，美国 33 个地点。
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):753-758. doi: 10.15585/mmwr.mm7020e2.
2
Diversity in immunogenomics: the value and the challenge.免疫基因组学的多样性：价值与挑战。
Nat Methods. 2021 Jun;18(6):588-591. doi: 10.1038/s41592-021-01169-5.
3
Embracing Genetic Diversity to Improve Black Health.拥抱基因多样性以改善黑人健康。
N Engl J Med. 2021 Mar 25;384(12):1163-1167. doi: 10.1056/NEJMms2031080. Epub 2021 Feb 10.
4
Clinical Genetics Lacks Standard Definitions and Protocols for the Collection and Use of Diversity Measures.临床遗传学缺乏多样性衡量标准的定义和收集使用的标准规范。
Am J Hum Genet. 2020 Jul 2;107(1):72-82. doi: 10.1016/j.ajhg.2020.05.005. Epub 2020 Jun 6.
5
Genetic Ancestry Testing: What Is It and Why Is It Important?基因血统检测：它是什么以及为何重要？
JAMA. 2020 Mar 17;323(11):1089-1090. doi: 10.1001/jama.2020.0517.
6
Genome-wide Association Studies in Ancestrally Diverse Populations: Opportunities, Methods, Pitfalls, and Recommendations.全基因组关联研究在遗传背景多样化的人群中的应用：机遇、方法、陷阱和建议。
Cell. 2019 Oct 17;179(3):589-603. doi: 10.1016/j.cell.2019.08.051. Epub 2019 Oct 10.
7
Diversity of KIR, HLA Class I, and Their Interactions in Seven Populations of Sub-Saharan Africans.七个撒哈拉以南非洲人群的 KIR、HLA I 类及其相互作用的多样性。
J Immunol. 2019 May 1;202(9):2636-2647. doi: 10.4049/jimmunol.1801586. Epub 2019 Mar 27.
8
Using T Cell Receptor Repertoires to Understand the Principles of Adaptive Immune Recognition.利用 T 细胞受体库来理解适应性免疫识别的原理。
Annu Rev Immunol. 2019 Apr 26;37:547-570. doi: 10.1146/annurev-immunol-042718-041757. Epub 2019 Jan 30.
9
A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog.用于基因组学研究中祖先数据表示的标准化框架，及其在 NHGRI-EBI GWAS 目录中的应用。
Genome Biol. 2018 Feb 15;19(1):21. doi: 10.1186/s13059-018-1396-2.
Zotero 插件